American Patients Must Tell Congress to Fix the USMCA to Lower Drug Prices! @accessiblemeds
American Patients Must Tell Congress to Fix the USMCA to Lower Drug Prices!  @accessiblemeds
Uploaded May 2019 | Updated November 2026, 3 hours ago
Congress is deciding whether to approve the USMCA trade agreement (NAFTA 2.0). AAM’s Jonathan Kimball urges Americans to tell their member of Congress to stand up for patients and fix the provisions that increase drug prices and expand drug monopolies. Improving the USMCA by increasing patient access to more affordable generic and biosimilar medicine is possible.
Take Action Now! medsforamerica.org
#FixUSMCA
American Patients Must Tell Congress to Fix the USMCA to Lower Drug Prices!David Gaugh: Entertainment at GRx+Biosims 2018AAM Member Fresenius Kabi: Ali AhmedCOVID-19 Response: Anthony Maffia at Sandoz2016 GPhA Annual Meeting: CEOs UnpluggedMcKenzies Story - #medswithinreachAre Biosimilars Safe?Jenis Story | Biosimilars Gave Me My Life BackAccess! 2018 - Who You Need to HearAAM All Access Mary Beth Powers of CMMBSandoz US is #RemarkablyGenericAAM All Access - Monét Stanford & Lisa Parks
Association for Accessible Medicines |

American Patients Must Tell Congress to Fix the USMCA to Lower Drug Prices!

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER